The Influence of a Fasting Mimicking Diet on Ulcerative Colitis

Description

The purpose of this study is to see how a diet that mimics fasting effects inflammation in patients with mild to moderate Ulcerative Colitis (UC). The diet may allow users to receive the benefits of fasting while also being able to enjoy food (the ingredients of which are GRAS (generally recognized as safe) by the Food and Drug Administration (FDA). Research on dietary interventions and UC are very limited. Fasting mimicking diets (FMD) have been studied with support of the National Institute of Health and published in leading journals. This research investigates whether markers of inflammation decrease and/or quality of life increases after three cycles of a five-day period of the fasting mimicking diet, and may provide rationale for its use to treat UC.

Conditions

Inflammatory Bowel Disease, Diet Modification, Ulcerative Colitis

Talk to us

Study Overview

On this page

Study Details

Study overview

The purpose of this study is to see how a diet that mimics fasting effects inflammation in patients with mild to moderate Ulcerative Colitis (UC). The diet may allow users to receive the benefits of fasting while also being able to enjoy food (the ingredients of which are GRAS (generally recognized as safe) by the Food and Drug Administration (FDA). Research on dietary interventions and UC are very limited. Fasting mimicking diets (FMD) have been studied with support of the National Institute of Health and published in leading journals. This research investigates whether markers of inflammation decrease and/or quality of life increases after three cycles of a five-day period of the fasting mimicking diet, and may provide rationale for its use to treat UC.

The Influence of a Fasting Mimicking Diet on Ulcerative Colitis

The Influence of a Fasting Mimicking Diet on Ulcerative Colitis

Condition
Inflammatory Bowel Disease
Intervention / Treatment

-

Contacts and Locations

Palo Alto

Stanford University, Palo Alto, California, United States, 94305

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Mild to moderate Ulcerative Colitis on the partial Mayo Score out of 9 (score between 2 to 7)
  • * Age of 18-70 at start of study (inclusive)
  • * Women who are pregnant or nursing or expect to be pregnant
  • * Individuals allergic to nuts
  • * Individuals with a body mass index (BMI) lower than 18
  • * Individuals diagnosed with a serious medical condition as defined by the patient's physician, unless approved in writing by a physician
  • * Individuals who have been severely weakened by a disease or medical procedure,
  • * Individuals who are taking medication which may not be safely consumed with a calorie restricted diet
  • * Individuals with diabetes who are taking anti-diabetic drugs associated with risk of hypoglycemia
  • * Individuals with more than mild-moderate cardiovascular disease or life-threatening cancer (as determined by patient's physician) unless approved by a physician
  • * Individuals with history of severe cardiac disease (particularly uncompensated congestive heart failure NYHA grade 2 or more or LVEF \< 40%)
  • * Individuals with a history of syncope
  • * Individuals with dietary needs incompatible with the FMD meal plan
  • * Individuals with liver or kidney disorders that may be affected by very low glucose and protein content of the diet.
  • * Patients on a caloric restricted diet will also be excluded.
  • * Patients with relevant prior gastrointestinal surgery and consequences such as short bowel syndrome, ostomy of small or large intestine, hemi- or total colectomy, proctocolectomy, ileoanal pouch will be excluded.

Ages Eligible for Study

18 Years to 70 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Stanford University,

Sidhartha R Sinha, MD, PRINCIPAL_INVESTIGATOR, Stanford University

Study Record Dates

2025-12